Purchase Order 19PCRD26K1805
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a purchase order award from the Bureau of Administration valued at $11,500.00 with a firm fixed price contract type. The award, dated July 31, 2025, has an ultimate completion date of July 31, 2025 and involves part number adjustments. The contract was awarded without a set-aside designation, indicating open competition. The place of performance is located in Lockhart, Florida. Based on Abbott Rapid DX North...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $3,600.00 for COVID-19 viral test kits containing 24 tests. The contract, issued on November 14, 2025, with an ultimate completion date of November 25, 2025, utilizes a fixed-price structure with economic price adjustment provisions. The award was made without a set-aside designation on a full and open competitive basis by the Defense Logistics Agency Medical Supply Chain, a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $12,720.00 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain on October 15, 2025, with an ultimate completion date of October 21, 2025. The contract, which carries no set-aside designation and indicates open competition, is for a kit identification, now strip A2 qualification detector mobile/mobile laboratory test. Performance will occur in...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on September 5, 2025, for COVID-19 test kits valued at $15,000.00 with a completion date of September 16, 2025. This fixed-price contract with economic price adjustment clauses was awarded without set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain funded this award, and performance will be completed in Lockhart, Florida. The delivery order...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on September 17, 2025, for COVID-19 diagnostic test kits under contract 4569502136. The order, valued at $3,600.00 with a fixed-price contract type that includes economic price adjustment provisions, is scheduled for completion by September 26, 2025. The products will be delivered to Lockhart, Florida, and the award was made by the Defense Logistics Agency Medical Supply Chain without a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a firm fixed-price purchase order valued at $11,896.50 for medical supplies by the Bureau of Administration on February 5, 2026, with an ultimate completion date of March 6, 2026. The contract will be performed in Lake Mary, Florida. This award reflects no set-aside designation and was competed on a full and open basis. Abbott Rapid DX North America LLC, doing business as Alere North America LLC, is a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on April 28, 2025, for COVID-19 test kits with a ceiling value of $2,400.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of May 7, 2025, and will be performed in Lockhart, Florida. The contract was awarded without a set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain, operating under...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, was awarded a $1,344.00 delivery order contract on August 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for diagnostic testing supplies and equipment. The contract, designated as a fixed-price agreement with economic price adjustment, calls for delivery of ID NOW Strep A Qualification Detection Mobile Lab Test kits to Lockhart, Florida, with an ultimate completion date of August 19, 2025. This delivery...
- This is a $16,875.00 firm-fixed price purchase order contract awarded to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, by the Bureau of Administration, a civilian federal agency. The contract is for the delivery of medical supplies, with a completion date of January 12, 2024. It does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to various government agencies,...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. The contract, valued at $12,060.60, is for the delivery of medical supplies. The period of performance runs through February 1, 2024. This award does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, in vitro...
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a Purchase Order for medical supplies valued at $15,678.00 by the Bureau of Administration on December 12, 2025. The contract is structured as a firm fixed-price award with no set-aside designation and will be performed in Lake Mary, Florida, with an ultimate completion date of January 10, 2026. Abbott Rapid DX specializes in point-of-care testing devices and diagnostic supplies, including COVID-19 antigen tests, rapid diagnostic platforms, and clinical testing technologies that support federal healthcare agencies' medical readiness and public health initiatives. Abbott Rapid DX has established itself as a critical supplier within the federal healthcare procurement landscape through an extensive portfolio of contracts with the Department of Veterans Affairs, Defense Logistics Agency, Defense Health Agency, and other federal agencies. The company maintains multiple indefinite delivery vehicle agreements, including blanket purchase agreements and delivery orders across Veterans Integrated Service Networks, enabling efficient procurement of diagnostic testing products and services on an as-needed basis. This purchase order represents a continuation of Abbott's sustained performance in supplying essential medical diagnostic equipment and testing supplies to federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 12/12/25 |